1Boulton A J, Vileikyte L, Ragnarson - Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet, 2005, 366 ( 9498 ) :1719 -24.
2Eisenbarth GS, Polonsky KS, Buse JB. Type I diabetes mellitus. Williams textbook of endocrinology. Eds: Larsea PR, Kronenberg HM, Melmed S, Polonsky KS. Saunders. Phildelphia, Pennsylvania, 2003. 1485 - 1508.
3The effect of intensive treatment of diabetes on the development and progression of long - term complications in insulin - dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993, 329 (14): 977-986.
4Garber A. The effect of intensive treatment of diabetes mellitus. N Engl J Med 1994, 330 (9): 641 -642.
6Continous subcutaneous insulin infusion. American Diabetes Association.Diabetes Care, 2002, 25 (suppl 1): 116.
7Melville B. The insulin pump: why not use it for every type I diabetic patient? Crit Care Nuts, 2005, 28 (4) : 370 -377.
8Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 2003, 25:593-598.
9Torrance T, Franklin V, Greene S. Insulin pumps. Arch Dis Child,2003, 88 : 949 - 953.
10Ahem JAH, Boland E, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbAIC levels across all age groups. Pediatr Diabetes, 2002, 3: 10-15.
二级参考文献8
1Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes, Health Technology Assessment 2004;8:43.
2Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26:1079 - 1087.
3Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials, BMJ 2002; 324: 705.
4Pickup J, Keen H. Continuous subcutaneous insulin infusion at25 Years, Diabetes Care 2002 ;25: 593 - 598.
5Plotnick LP, Clark LM, Brancat FL, et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26:1142 - 1146.
6Hanas R. Selection for and initiat ion of continuous subcutaneous insulin infusion. Horm Res 2002;57(suppl 1):101- 104.
7Simmons D, Thompson CF, Conroy C, et al. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community, Diabetes Care 2001; 24:2078 -2082.
8Steel JM, Johnstone FD, Hume R, et al. Insulin requirements during pregnancy in women with type 1 diabetes. Obstet Gynecol1994; 83: 253 - 258.
10Manitatis A K, Klingensmith C J, Slover R H, et al. Continuous subcutaneous insulin infusion therapy for children and adolesccns: an option for routine dabetes care[J]. Pediatrics, 2001, 107: 351.
